117 related articles for article (PubMed ID: 8813099)
41. [2-chlorodeoxyadenosine (2-CdA) cladribine therapy in hairy cell leukemia].
Raanani P; Shpilberg O; Ben-Bassat I
Harefuah; 1994 Jun; 126(11):673-6. PubMed ID: 7927005
[No Abstract] [Full Text] [Related]
42. Pegfilgrastim prophylaxis for cladribine-induced neutropenia in patients with hairy-cell leukemia.
Goldschmidt N; Ganzel C; Attias D; Gatt M; Polliack A; Tadmor T
Acta Haematol; 2014; 132(1):118-21. PubMed ID: 24557414
[No Abstract] [Full Text] [Related]
43. [Treatment of hairy cell leukemia with cladribine].
Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
[TBL] [Abstract][Full Text] [Related]
44. Gynecomastia in a case of hairy cell leukaemia--cladribine induced?
Abhyankar D; Saikia T; Advani S
Leuk Lymphoma; 2001 Jun; 42(1-2):243-6. PubMed ID: 11699216
[TBL] [Abstract][Full Text] [Related]
45. Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: treatment- or disease-related?
Urosevic-Maiwald M; Nobbe S; Kerl K; Benz R
J Dermatol; 2014 Apr; 41(4):329-33. PubMed ID: 24612373
[TBL] [Abstract][Full Text] [Related]
46. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
Araki H; Matsunaga T; Murase K; Kuroda H; Kuribayashi K; Terui T; Niitsu Y
Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122
[TBL] [Abstract][Full Text] [Related]
47. Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell Leukemia.
Damasio EE; Resegotti L; Masoudi B; Bruni R; Cerri R; Isaza A; Clavio M; Risso M; Rossi E; Spriano M; Truini M
Recenti Prog Med; 1998 Feb; 89(2):68-73. PubMed ID: 9558908
[TBL] [Abstract][Full Text] [Related]
48. Interferon in the treatment of hairy-cell leukemia.
Ahmed S; Rai KR
Best Pract Res Clin Haematol; 2003 Mar; 16(1):69-81. PubMed ID: 12670466
[TBL] [Abstract][Full Text] [Related]
49. Cladribine: from the bench to the bedside--focus on hairy cell leukemia.
Greyz N; Saven A
Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311
[TBL] [Abstract][Full Text] [Related]
50. 2-chlorodeoxyadenosine-associated transient acantholytic dermatosis in hairy cell leukemia patients.
Cohen PR; Kurzrock R
Am J Dermatopathol; 1999 Feb; 21(1):106-8. PubMed ID: 10027536
[No Abstract] [Full Text] [Related]
51. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
Rai KR
Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
[TBL] [Abstract][Full Text] [Related]
52. [Bone marrow fibrosis during therapy of hairy cell leukemia].
Dĕdic K; Zák P
Cesk Patol; 2004 Jan; 40(1):22-4. PubMed ID: 15035057
[TBL] [Abstract][Full Text] [Related]
53. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
54. Lack of toxicity in a cladribine extravasation.
Mateu-de Antonio J; Acuña-Reina L; Pons JC; Buisán MJ
Ann Pharmacother; 1999; 33(7-8):873. PubMed ID: 10466922
[No Abstract] [Full Text] [Related]
55. Hairy cell leukemia: current concepts.
Cannon T; Mobarek D; Wegge J; Tabbara IA
Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
[TBL] [Abstract][Full Text] [Related]
56. Cutaneous reactions after treatment with 2-chlorodeoxyadenosine.
Meunier P; Castaigne S; Bastie JN; Chosidow O; Aractingi S
Acta Derm Venereol; 1996 Sep; 76(5):385-6. PubMed ID: 8891014
[TBL] [Abstract][Full Text] [Related]
57. Purpuric exanthema in a patient with hairy cell leukemia treated with cladribine and allopurinol.
Espinosa Lara P; Quirós Redondo V; Aguado Lobo M; Jiménez-Reyes J
Ann Hematol; 2017 Jul; 96(7):1209-1210. PubMed ID: 28391438
[No Abstract] [Full Text] [Related]
58. Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature.
Setoodeh R; Zhang L
Leuk Lymphoma; 2012 Apr; 53(4):736-8. PubMed ID: 21980957
[No Abstract] [Full Text] [Related]
59. Effective treatment of autoimmune hemolytic anemia and hairy cell leukemia with interferon-alpha.
Cesana C; Brando B; Boiani E; Chiodo F; Cairoli R; Intropido L; Morra E
Eur J Haematol; 2002 Feb; 68(2):120-1. PubMed ID: 11982619
[No Abstract] [Full Text] [Related]
60. Cutaneous adverse events associated with purine analogs in the treatment of hairy cell leukemia.
Wang RF; Kuehn GJ; Andritsos LA; Grever MR; Kaffenberger BH
Int J Dermatol; 2019 May; 58(5):e109-e110. PubMed ID: 30478890
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
